Home
News Open submenu
About MedNous Open submenu
Research Directory Open submenu
Contact Us Open submenu

Close submenu News

News
Appointments
Events

Close submenu About MedNous

Who We Are
Editorial Board
Editorial Policy

Close submenu Research Directory

Research Directory
Organisations
Interviewees
Terms
Topics

Close submenu Contact Us

Contact Form

Skip to main content

15 June 2025

Last updated: Sunday 15 June 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Merck Serono Ventures invests in early technology

Monday 15 June 2009

Interviewee/Contributor

Roel Bulthuis

Organisation

Merck Serono Ventures

Organisations

Zealand Pharma A/S
International Society Cell and Gene Therapy
Molecular Health GmbH
F-Star GmbH
Evox Therapeutics Ltd
Immunicum AB
Immatics Biotechnologies GmbH
BDO LLP
Philogen SpA
AM-Pharma BV

Interviewees and Contributers

Bradley Bolzon
Piet Wigerinck and Walid Abi-Saab
Jennifer Bailey
Stéphane Degove
Renée Aguiar-Lucander
John Mayo
David Mott
Philippe Villain-Guillot
Geoffrey Guy
Deborah O-Neil

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.